President Donald Trump signed an executive order Thursday that could slap long-threatened pharmaceutical tariffs of up to 100% on some patented drugs from companies that don't reach deals with his administration in the coming months. Companies that have signe…
Trump unveils 100% tariff on some patented drugs on 'Liberation Day' anniversary
President Donald Trump signed an executive order authorizing up to 100% tariffs on patented drugs from manufacturers that fail to negotiate pricing deals with his administration by a specified deadline. The policy targets pharmaceutical companies with patented drugs, potentially disrupting global supply chains and increasing costs for consumers and healthcare systems. Affected stakeholders must comply with pricing negotiations or face severe financial penalties within a short timeframe.